Home » Topics » BioWorld Science

BioWorld Science
RSS

Indivior begins first-in-human study of INDV-2000 for opioid dependence

July 9, 2020

Enrollment completed in phase II study of mRNA-1273 for COVID-19

July 9, 2020

DECR1 unveiled as a potential therapeutic target in prostate cancer

July 9, 2020

New anti-PD-1 antibody YBL-006 shows high receptor affinity, in vivo activity

July 9, 2020

NextCure initiates phase I/II trial of LAIR-2 biomimic NC-410

July 9, 2020

Angion begins phase II study in Brazil with ANG-3777 in patients with COVID-19 pneumonia

July 9, 2020

Eternity Bioscience patents hSTING receptor agonists

July 9, 2020

Bicyclerd identifies new IL-17 ligands

July 9, 2020

Esteve Pharmaceuticals presents new analgesics

July 9, 2020

Global Blood Therapeutics divulges SLC40A1 inhibitors

July 9, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...